AIDS research group amfAR has taken a stand against the Trans-Pacific Partnership (TPP), a 12-nation trade deal for which President Obama hopes to gain "fast-track" authority.
According to a new amfAR report, the TPP's provisions about pharmaceutical companies could increase the cost of drugs in the developing world. The report claims that the trade deal's provisions would hinder AIDS treatment, because it could delay the introduction of generic, lower-cost treatments.
The report suggests the TPP could expand intellectual property protections and expand what qualifies for patents, which "would tilt the playing field in favor of drug companies," Vox explains. The provisions could delay the availability of generic medicines, because during the large companies' patent monopolies over the medicines, other companies couldn't create generic versions.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Vox notes that the TPP could also enforce "data exclusivity," requiring generic producers to conduct their own clinical trials, rather than using data from the large companies' original tests. Conducting additional trials would cost generic producers time and resources, which could also delay generics' introduction into the market.
"The global community would never have achieved its successes in addressing the HIV epidemic if the terms of the proposed TPP were the international standard in 2001," amfAR said in the report, adding that the TPP's provisions "show a disregard for public health."
-
Why ‘anti-Islam’ bikers are guarding Gaza aid sitesIn The Spotlight Members of Infidels MC, who regard themselves as modern Crusaders, among private security guards at Gaza Humanitarian Foundation sites
-
China: Xi seeks to fill America’s voidFeature Trump’s tariffs are pushing nations eastward as Xi Jinping focuses on strengthening ties with global leaders
-
Rebrands: Bringing back the War DepartmentFeature Trump revives the Department of Defense’s former name
-
House posts lewd Epstein note attributed to TrumpSpeed Read The estate of Jeffrey Epstein turned over the infamous 2003 birthday note from President Donald Trump
-
Supreme Court allows 'roving' race-tied ICE raidsSpeed Read The court paused a federal judge's order barring agents from detaining suspected undocumented immigrants in LA based on race
-
South Korea to fetch workers detained in Georgia raidSpeed Read More than 300 South Korean workers detained in an immigration raid at a Hyundai plant will be released
-
DC sues Trump to end Guard 'occupation'Speed Read D.C. Attorney General Brian Schwalb argues that the unsolicited military presence violates the law
-
RFK Jr. faces bipartisan heat in Senate hearingSpeed Read The health secretary defended his leadership amid CDC turmoil and deflected questions about the restricted availability of vaccines
-
White House defends boat strike as legal doubts mountSpeed Read Experts say there was no legal justification for killing 11 alleged drug-traffickers
-
Epstein accusers urge full file release, hint at own listspeed read A rally was organized by Reps. Ro Khanna and Thomas Massie, who are hoping to force a vote on their Epstein Files Transparency Act
-
Court hands Harvard a win in Trump funding battleSpeed Read The Trump administration was ordered to restore Harvard's $2 billion in research grants
